Faculty Publications
Permanent URI for this communityhttps://idr.nitk.ac.in/handle/123456789/18736
Publications by NITK Faculty
Browse
3 results
Search Results
Item Pharmaceutical salts of ethionamide with GRAS counter ion donors to enhance the solubility(Elsevier B.V., 2017) Nechipadappu, S.K.; Trivedi, D.R.Pharmaceutical salts of BCS class II second line anti-tuberculosis drug ethionamide (ETH) with various counter ions namely, 2-chloro-4-nitrobenzoic acid (CNB), 2,6-dihydroxybenzoic acid (2,6HBA), 2,3-dihydroxybenzoic acid (2,3HBA) and 2,4-dinitrobenzoic acid (DNB) were synthesized by crystal engineering approach. All the synthesized salts were characterized by various spectroscopic (NMR, FT-IR,), thermal (DSC & TGA) and PXRD techniques. The crystal structure of the synthesized salts was determined by single-crystal X-ray diffraction techniques. All the reported salts, except ETH-2,3HBA exhibited charge assisted acid pyridine heterosynthon. In ETH-2,3HBA hydoxyl pyridine heterosynthon is observed. In ETH-CNB salt, both ionic and neutral acid pyridine heterosynthon were observed in the asymmetric unit. ETH-DNB salt consists of both partial and complete proton transfer from DNB to ETH in the asymmetric unit. All the synthesized salts were found to be non-hygroscopic at accelerated humid condition (~ 75% RH). Solubility experiment has been performed in purified water and in 0.1 N HCl (pH = 1) solution and found that the solubility of ETH-CNB salt was about eight-fold higher soluble than ETH in purified water. The solubility of synthesized salts follows the order of ETH < ETH-2,3HBA < ETH-2,6HBA < ETH-CNB in purified water. © 2016 Elsevier B.V.Item Pharmaceutical Co-Crystal of Flufenamic Acid: Synthesis and Characterization of Two Novel Drug-Drug Co-Crystal(Elsevier B.V., 2017) Nechipadappu, S.K.; Tekuri, V.; Trivedi, D.R.Two novel pharmaceutical co-crystals of anti-inflammatory drug flufenamic acid (FFA) with 2-chloro-4-nitrobenzoic acid (CNB) and ethenzamide (ETZ) have been synthesized by solvent evaporation method as well as by solvent drop-assisted grinding method. The synthesized co-crystals were characterized thoroughly by various spectroscopic methods and crystal structures were determined by single-crystal x-ray diffraction technique. In FFA-CNB co-crystal, robust supramolecular acid-acid homosynthon was observed. FFA-ETZ co-crystal is formed via robust supramolecular acid-amide heterosynthon. In FTIR spectra, a significant shift in the carbonyl stretching frequency was observed for the co-crystals due to the presence of intermolecular hydrogen bond. 1H nuclear magnetic resonance study suggests the presence of hydrogen bond in the solution state of FFA-ETZ co-crystal; however, it was absent for FFA-CNB co-crystal. Solubility study in Millipore water revealed that the solubility of FFA is increased by 2-fold when it is in the form of FFA-CNB co-crystal and no increment in the solubility of FFA was observed in FFA-ETZ co-crystal. About 5-fold increment in the solubility of FFA was observed in both the co-crystals in 0.1 N HCl (pH 1) solution. The synthesized co-crystals were found to be non-hygroscopic at ?75% relative humidity and stable for a period of 6 months at ambient temperature (?25°C). © 2017 American Pharmacists Association®Item Synthesis of cocrystals/salts of flucytosine: Structure and stability(Royal Society of Chemistry, 2018) Nechipadappu, S.K.; Ramachandran, J.; Naveen, N.; Lokanath, N.K.; Trivedi, D.R.5-Fluorocytosine or flucytosine (FLC) is a well-known drug for anti-fungal treatment and is one of the essential medicines needed in a health system. The main disadvantage of FLC drugs is their instability due to hydration under storage conditions. In the present work, cocrystal/salt screening experiments resulted in three molecular salts of FLC with dihydroxybenzoic acid derivatives, 2,3-dihydroxybenzoic acid (2,3HBA), 3,5-dihydroxybenzoic acid (3,5HBA), and 2,6-dihydroxybenzoic acid (2,6HBA), and two cocrystals with gallic acid (GAA) and glutaric acid (GLA). Since FLC drugs are highly susceptible to hydration, the present work concentrated on the stability of the synthesized molecular salts/cocrystals under different relative humidity (RH) conditions. All the newly formed crystalline adducts were characterized structurally, and the crystal structures were determined using single-crystal X-ray diffraction techniques (SCXRD). The FLC-2,6HBA salt was found to be a monohydrate, whereas the FLC-3,5HBA salt was crystallized as a hemipentahydrate. FLC-2,3HBA and FLC-GLA were crystallized in 2:1 equimolar ratios of FLC and the coformer. The FLC-GAA cocrystal crystallized in a 1:1 equimolar ratio. Two point heterosynthons between FLC and the coformer were observed in all the crystalline structures except FLC-GLA, where the structure was formed through a single point heterosynthon. Stability studies under different relative humidity conditions showed the non-hygroscopicity of the synthesized molecular salts/cocrystals. It was found that the FLC-2,3HBA salt, and the FLC-GAA and FLC-GLA cocrystals did not experience any hydration under the accelerated humidity conditions (both 70-75% RH and 90-95% RH) at ambient temperature (?30 °C). However, FLC-2,6HBA and FLC-3,5HBA were found to be hygroscopic under 70-75% RH conditions. Furthermore, all the synthesized salts/cocrystals except FLC-3,5HBA were found to be stable for 2 months under ambient conditions (?30 °C, 60-65% RH). Therefore, the FLC-2,3HBA salt, and the FLC-GAA and FLC-GLA cocrystals are better candidates for the preparation of new drug products of FLC. © 2018 The Royal Society of Chemistry and the Centre National de la Recherche Scientifique.